Showing results (151-160 of 232) with videos related to
Sort By:
Pageof 24
Metabolism: Clinical and Experimental|October 1, 1995
Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjectsD L Cutler, C G Gray, S W Park, et al.The Laryngoscope|September 28, 2006
Fluorescent retrograde axonal tracing of the facial nerveMatthew R O'Malley, Justin E Wittkopf, Jeffrey L Cutler, et al.Biochemistry|April 18, 1989
Role of arginine-38 in regulation of the cytochrome c oxidation-reduction equilibriumR L Cutler, A M Davies, S Creighton, et al.Community Mental Health Journal|December 6, 2005
The Professor of Public Psychiatry Model in Ohio: the impact on training, program innovation, and the quality of mental health careDale P Svendsen, David L Cutler, Robert J Ronis, et al.Pharmaceutical Research|January 19, 1999
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10E Radwanski, A Chakraborty, S Van Wart, et al.Mental Health Services Research|March 21, 2001
Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual careG N Clarke, H A Herinckx, R F Kinney, et al.European Journal of Clinical Pharmacology|April 6, 2012
Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarinTeddy Kosoglou, Yali Zhu, Fengjuan Xuan, et al.British Journal of Clinical Pharmacology|March 12, 1999
Pharmacokinetics of flutamide in patients with renal insufficiencyS Anjum, S K Swan, L J Lambrecht, et al.Clinical Pharmacology and Therapeutics|August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, J Gallo, et al.Current Medical Research and Opinion|August 25, 2004
Pharmacodynamic interaction between ezetimibe and rosuvastatinTeddy Kosoglou, Paul Statkevich, Bo Yang, et al.Pageof 24